TP53 and lung adenocarcinoma: There were significant differences in somatic mutation mRNA-seq miRNA-seq immune infiltration and immunomodulator in patients with mutant LUAD suggesting that TP53 mutation plays a key role in the occurrence and development of lung adenocarcinoma [29].